263 related articles for article (PubMed ID: 11987155)
21. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
22. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S
Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073
[TBL] [Abstract][Full Text] [Related]
23. CD105 is important for angiogenesis: evidence and potential applications.
Duff SE; Li C; Garland JM; Kumar S
FASEB J; 2003 Jun; 17(9):984-92. PubMed ID: 12773481
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
[TBL] [Abstract][Full Text] [Related]
25. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
Fonsatti E; Del Vecchio L; Altomonte M; Sigalotti L; Nicotra MR; Coral S; Natali PG; Maio M
J Cell Physiol; 2001 Jul; 188(1):1-7. PubMed ID: 11382917
[TBL] [Abstract][Full Text] [Related]
26. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
[TBL] [Abstract][Full Text] [Related]
27. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA
APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
29. Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.
Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
Virchows Arch; 2006 Feb; 448(2):127-34. PubMed ID: 16177881
[TBL] [Abstract][Full Text] [Related]
30. High immunohistochemical expression of TGF-β1 predicts a poor prognosis in cervical cancer patients who harbor enriched endoglin microvessel density.
Lin H; Huang CC; Ou YC; Huang EY; Changchien CC; Tseng CW; Fu HC; Wu CH; Li CJ; Ma YY
Int J Gynecol Pathol; 2012 Sep; 31(5):482-9. PubMed ID: 22833091
[TBL] [Abstract][Full Text] [Related]
31. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer.
Wikström P; Stattin P; Franck-Lissbrant I; Damber JE; Bergh A
Prostate; 1998 Sep; 37(1):19-29. PubMed ID: 9721065
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms.
Henriksen R; Gobl A; Wilander E; Oberg K; Miyazono K; Funa K
Lab Invest; 1995 Aug; 73(2):213-20. PubMed ID: 7637321
[TBL] [Abstract][Full Text] [Related]
34. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.
Kumar S; Ghellal A; Li C; Byrne G; Haboubi N; Wang JM; Bundred N
Cancer Res; 1999 Feb; 59(4):856-61. PubMed ID: 10029075
[TBL] [Abstract][Full Text] [Related]
35. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
36. Assessment of vascularity as an index of angiogenesis in periradicular granulomas. Comparison with oral carcinomas and normal tissue counterparts.
Davey KJ; Perrier S; Ohe G; Gilbert AD; Bankfalvi A; Saunders WP; Schor SL; Schor AM
Int Endod J; 2008 Nov; 41(11):987-96. PubMed ID: 19133088
[TBL] [Abstract][Full Text] [Related]
37. The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count.
Romani AA; Borghetti AF; Del Rio P; Sianesi M; Soliani P
J Surg Oncol; 2006 May; 93(6):446-55. PubMed ID: 16615157
[TBL] [Abstract][Full Text] [Related]
38. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.
Dallas NA; Samuel S; Xia L; Fan F; Gray MJ; Lim SJ; Ellis LM
Clin Cancer Res; 2008 Apr; 14(7):1931-7. PubMed ID: 18381930
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
[TBL] [Abstract][Full Text] [Related]
40. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1998; 18(4A):2701-10. PubMed ID: 9703932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
